La Fin d'Alzheimer : le premier programme qui prévient et inverse le déclin cognitif
ReCODE is a program designed for Alzheimer’s patients, pre-Alzheimer’s individuals, and those at high risk of developing the disease, aimed at preventing cognitive decline through dietary, hormonal, inflammatory, toxic, and physical interventions.
- The description claims that 9 out of 10 patients showed significant improvements after following the ReCODE protocol for several months.
- The description claims that more than half of the patients who followed ReCODE no longer have any symptoms.
Variants (1)
- Default Title — 40.95 CAD — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
75%